Stockreport

Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients [Read more]